PID-atom distributions for all subjects under different drugs and placebo effects using MMI definition.
Alberto Liardi (22305679), Fernando E. Rosas (9595503), Robin L. Carhart-Harris (5923571), George Blackburne (22305682), Daniel Bor (297008), Pedro A. M. Mediano (5786234)
OPAL (Open@LaTrobe) (La Trobe University) November 5, 2025 DOI: 10.1371/journal.pcbi.1013629.g004 via OpenAlex
Summary
AI-generated from the abstractThe figure displays results for LSD, ketamine, and psilocybin across three rows: raw PID atoms, NMI-normalized PID atoms, and NuMIT-normalized PID atoms. Dashed lines mark zero. P-values were computed using a one-sample t-test against a zero-mean null hypothesis, with asterisks indicating p < 0.001. No further details on findings or sample are provided.
Study at a glance
| Characteristics | Peer reviewed |
|---|---|
| Keywords | Pid controller Placebo Internal medicine Pharmacology |
| Key finding | The figure presents PID atom values for LSD, ketamine, and psilocybin, with significance indicated at p<0.001. |
Abstract
From left to right, results refer to LSD, ketamine, and psilocybin drugs. Panel rows represent (a) the raw values of PID atoms, (b) the NMI-normalised PID atoms, and (c) the NuMIT-normalised PID atoms. The dashed black lines are drawn at zero. (P-values calculated with a one-sample t-test against the zero-mean null hypothesis. *: ppp<0.001).